Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA's...

Area of Science:

• Respiratory Medicine
• Molecular Diagnostics
• Infectious Disease

Background:

• Clinical signs of acute respiratory tract infections (RTIs) are often non-specific, complicating diagnosis.
• Nucleic acid amplification tests (NAATs) are the gold standard for viral diagnostics.
• Molecular assays for bacterial RTIs are emerging as significant advancements in clinical practice.

Purpose of the Study:

• To summarize the current state of molecular diagnostics for viral and bacterial RTIs.
• To provide a practical framework for integrating new molecular tests with clinical judgment.
• To offer recommendations for future research to advance the field of respiratory infection diagnosis.

Main Methods:

• Review of current molecular diagnostic technologies for RTIs.
• Analysis of the role of molecular diagnostics in the COVID-19 pandemic.
• Development of a diagnostic decision-making framework using patient vignettes.

Main Results:

• Molecular diagnostics have become essential for identifying respiratory pathogens.
• The rapid evolution of technologies presents challenges in optimal test utilization.
• A framework is proposed to guide the combined use of molecular tests, clinical judgment, and traditional methods.

Conclusions:

• Molecular diagnostics represent a significant advancement in diagnosing viral and bacterial RTIs.
• Integrating these tests effectively requires a strategic approach combining technology with clinical expertise.
• Further research is needed to refine diagnostic strategies and optimize patient care for RTIs.